Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 183 entries
View as:

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00122239 Org: User:
Start: 01/31/05 End: 02/28/17 Due: 02/28/18

A Study to Determine the Value of 18F-FAZA PET Imaging in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00771381 Org: User:
Start: 11/28/08 End: 02/04/19 Due: 02/04/20

Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01411072 Org: User:
Start: 09/30/11 End: 12/31/15 Due: 12/31/16

Conventional Versus Hypofractionated Radiation in High Risk Prostate Patients

Phase: N/A Priority: Normal
NCT ID: NCT01488968 Org: User:
Start: 03/31/12 End: 12/31/21 Due: 12/31/22

Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00756392 Org: User:
Start: 10/31/08 End: 04/30/14 Due: 04/30/15

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Phase: N/A Priority: Normal
NCT ID: NCT00314470 Org: User:
Start: 01/31/06 End: 03/31/09 Due: 03/31/10

Aerobic Capacity and Body Composition in Colon Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00470782 Org: User:
Start: 10/31/07 End: 10/31/09 Due: 10/31/10

Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients

Phase: N/A Priority: Normal
NCT ID: NCT04765514 Org: User:
Start: 07/27/22 End: 06/30/32 Due: 06/30/33

A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05712174 Org: User:
Start: 09/14/23 End: 05/05/25 Due: 05/05/26

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04952480 Org: User:
Start: 06/13/22 End: 11/01/25 Due: 11/01/26

Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00705094 Org: User:
Start: 09/30/08 End: 07/31/12 Due: 07/31/13

This Study is Comparing Morning vs Random Scheduling of Standard of Care Pembrolizumab Checkpoint Inhibitor Immunotherapy Infusions in Patients With Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06882174 Org: User:
Start: 10/06/25 End: 12/31/27 Due: 12/31/28

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01624051 Org: User:
Start: 07/31/14 End: 09/30/15 Due: 09/30/16

Loratadine for the Prevention of G-CSF-related Bone Pain

Phase: N/A Priority: Normal
NCT ID: NCT05421416 Org: User:
Start: 11/28/24 End: 12/01/26 Due: 12/01/27

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

Phase: N/A Priority: Normal
NCT ID: NCT04268199 Org: User:
Start: 05/29/20 End: 05/31/25 Due: 05/31/26

mHealth Physical Activity Intervention for Young Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT04765241 Org: User:
Start: 09/27/21 End: 06/30/26 Due: 06/30/27

A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00566410 Org: User:
Start: 12/31/07 End: 03/31/13 Due: 03/31/14

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02795572 Org: User:
Start: 06/27/17 End: 08/31/17 Due: 08/31/18

Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)

Phase: N/A Priority: Normal
NCT ID: NCT06001125 Org: User:
Start: 08/12/24 End: 11/30/29 Due: 11/30/30

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland

Phase: N/A Priority: Normal
NCT ID: NCT02004418 Org: User:
Start: 03/31/14 End: 09/30/20 Due: 09/30/21

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00123760 Org: User:
Start: 02/29/04 End: 12/31/08 Due: 12/31/09

An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00131612 Org: User:
Start: 01/31/02 End: 01/31/13 Due: 01/31/14

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06827886 Org: User:
Start: 09/06/23 End: 09/09/24 Due: 09/09/25

Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT01996696 Org: User:
Start: 09/30/14 End: 11/30/20 Due: 11/30/21

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00888823 Org: User:
Start: 03/31/10 End: 06/30/14 Due: 06/30/15